×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DYAI – dyadic international, inc. (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DYAI
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/17
07:20 am
dyai
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets
Low
Report
Dyadic and Fermbox Bio Expand Strategic Collaboration to Accelerate Commercialization of Animal-Free Proteins and Enzymes Across Life Science, Food & Nutrition, and Bioindustrial Markets
12/15
07:20 am
dyai
Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins
Medium
Report
Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins
12/2
03:41 pm
dyai
Dyadic International (NASDAQ:DYAI) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Dyadic International (NASDAQ:DYAI) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
12/1
07:25 am
dyai
Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets
Medium
Report
Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets
11/12
09:08 pm
dyai
Dyadic International, Inc. (DYAI) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Dyadic International, Inc. (DYAI) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/12
04:05 pm
dyai
Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress
Medium
Report
Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress
11/11
08:22 am
dyai
Dyadic International Inc (DYAI) Q3 2025 Earnings Report Preview: What To Expect [Yahoo! Finance]
Low
Report
Dyadic International Inc (DYAI) Q3 2025 Earnings Report Preview: What To Expect [Yahoo! Finance]
11/10
07:25 am
dyai
Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
High
Report
Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/14
05:22 pm
dyai
Form SCHEDULE 13G/A DYADIC INTERNATIONAL Filed by: EMALFARB MARK A
Low
Report
Form SCHEDULE 13G/A DYADIC INTERNATIONAL Filed by: EMALFARB MARK A
11/12
04:09 pm
dyai
Form 8-K DYADIC INTERNATIONAL For: Nov 12
Medium
Report
Form 8-K DYADIC INTERNATIONAL For: Nov 12
11/12
04:09 pm
dyai
Form 10-Q DYADIC INTERNATIONAL For: Sep 30
Medium
Report
Form 10-Q DYADIC INTERNATIONAL For: Sep 30
10/7
04:41 pm
dyai
Form 8-K DYADIC INTERNATIONAL For: Oct 06
Low
Report
Form 8-K DYADIC INTERNATIONAL For: Oct 06
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/18
Dyadic Presents New Business Opportunities to Address COVID-19, Influenza and Continued Scientific and Business Development Progress
63.2%
1/27 Dyadic to Interview with FOX Business Network on Monday, January 27, 2020 19.7%
5/9 Q1/2019 3/31/2019 EPS -0.080 ZacksConsensus N/A ActVsEst N/A - N/A 14.1%
2/27 Dyadic International, Inc (NASDAQ: DYAI) had its "buy" rating re-affirmed by analysts at Noble Financial. They now have a $11.00 price target on the stock. 10.3%
5/8 Form 8-K DYADIC INTERNATIONAL For: May 07 9.9%
6/27 Dyadic Announces Appointment of Ping Rawson to CFO 8.5%
3/30 Dyadic Reports 2019 Year End Results and Recent Developments 7.9%
5/8 Dyadic and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products and Vaccines 7.6%
3/30 Dyadic Announces Nonexclusive Research License with WuXi Biologics 7.3%
11/25 Dyadic Announces Achieving Human Like Glycan Structures From Its Engineered C1 Cell Line 7.2%
1/27 Dyadic to Interview with FOX Business Network on Monday, January 27, 2020 19.7%
5/9 Q1/2019 3/31/2019 EPS -0.080 ZacksConsensus N/A ActVsEst N/A - N/A 14.1%
2/27 Dyadic International, Inc (NASDAQ: DYAI) had its "buy" rating re-affirmed by analysts at Noble Financial. They now have a $11.00 price target on the stock. 10.3%
5/8 Form 8-K DYADIC INTERNATIONAL For: May 07 9.9%
6/27 Dyadic Announces Appointment of Ping Rawson to CFO 8.5%
3/30 Dyadic Reports 2019 Year End Results and Recent Developments 7.9%
5/8 Dyadic and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products and Vaccines 7.6%
3/30 Dyadic Announces Nonexclusive Research License with WuXi Biologics 7.3%
11/25 Dyadic Announces Achieving Human Like Glycan Structures From Its Engineered C1 Cell Line 7.2%
TOP News Decliners
3/16
Dyadic to Report Year End 2019 Financial Results on Monday, March 30, 2020
-20.2%
3/5 Dyadic International, Inc (NASDAQ: DYAI) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -10.9%
7/30 Dyadic to Report Second Quarter 2019 Financial Results on Tuesday August 13, 2019 -10.1%
2/26 Dyadic International, Inc (NASDAQ: DYAI) had its "buy" rating re-affirmed by analysts at Dawson James. -7.9%
6/20 Form 4 DYADIC INTERNATIONAL For: Jun 18 Filed by: TCHELET RONEN -7.6%
10/10 Dyadic to Attend Three Upcoming Investor Conferences in October -5.7%
5/12 Dyadic International, Inc (OTCMKTS: DYAI) had its "buy" rating re-affirmed by analysts at Noble Financial. They now have a $9.00 price target on the stock. -5.6%
12/12 Form 4 DYADIC INTERNATIONAL For: Dec 10 Filed by: TCHELET RONEN -5.4%
11/25 Form 8-K DYADIC INTERNATIONAL For: Nov 25 -4.8%
8/13 Dyadic International, Inc. (DYAI) CEO Mark Emalfarb on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -4.4%
3/5 Dyadic International, Inc (NASDAQ: DYAI) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. -10.9%
7/30 Dyadic to Report Second Quarter 2019 Financial Results on Tuesday August 13, 2019 -10.1%
2/26 Dyadic International, Inc (NASDAQ: DYAI) had its "buy" rating re-affirmed by analysts at Dawson James. -7.9%
6/20 Form 4 DYADIC INTERNATIONAL For: Jun 18 Filed by: TCHELET RONEN -7.6%
10/10 Dyadic to Attend Three Upcoming Investor Conferences in October -5.7%
5/12 Dyadic International, Inc (OTCMKTS: DYAI) had its "buy" rating re-affirmed by analysts at Noble Financial. They now have a $9.00 price target on the stock. -5.6%
12/12 Form 4 DYADIC INTERNATIONAL For: Dec 10 Filed by: TCHELET RONEN -5.4%
11/25 Form 8-K DYADIC INTERNATIONAL For: Nov 25 -4.8%
8/13 Dyadic International, Inc. (DYAI) CEO Mark Emalfarb on Q2 2019 Results - Earnings Call Transcript [Seeking Alpha] -4.4%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: